Kudo, M. (2021). A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers.
Style de citation Chicago (17e éd.)Kudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.
Style de citation MLA (8e éd.)Kudo, Masatoshi. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion. Karger Publishers, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.